DiaMedica Therapeutics (NASDAQ:DMAC) said it is looking to raise $11.8M through the sale of its common shares in a private placement with accredited investors. Shares in the company were up 13% in premarket trade. The firm will issue a total of 4.72M shares at $2.50 apiece. The financing is expected to extend theContinue Reading
cagkansayin Agile Therapeutics (OTC:AGRX) said on Wednesday that the Spain-based pharmaceutical group Insud Pharma is set to acquire the women’s healthcare company, valuing AGRX at an enterprise value of ~$45M. Insud’s U.S. subsidiary, Exeltis Project, will merge with Agile as part of the transaction. The transaction is priced at $1.52Continue Reading
manassanant pamai Augustine Therapeutics, focused on novel treatments for neurodegenerative and cardio metabolic diseases, Wednesday said that it has raised €17 million ($18.5 million) in the first closing of its Series A round. The financing was led by Asabys Partners, with participation from Eli Lilly and Company (NYSE:LLY), and theContinue Reading
vzphotos/iStock Editorial via Getty Images Cerevel Therapeutics (NASDAQ:CERE) fell 5.5% as investors wait to hear if the Federal Trade Commission will approve its planned $8.7 billion sale to AbbVie (NYSE:ABBV). The deal spread is the widest since the transaction was announced in early December. While there was no specific reasonContinue Reading
